nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
215 Adherence with TOBI® among cystic fibrosis patients with Pseudomonas aeruginosa infection
|
Joish, V.N. |
|
2011 |
10 |
Supplement 2 |
p. S55- 1 p. |
artikel |
2 |
Ambulatory quantitative waking and sleeping cough assessment in patients with cystic fibrosis
|
Kerem, Eitan |
|
2011 |
10 |
Supplement 2 |
p. 193-200 8 p. |
artikel |
3 |
122 A one-year experience of routine identification by MALDI-TOF MS of non-fermenting Gram-negative rods recovered from respiratory samples from cystic fibrosis patients
|
Olmos, A. Fernandez |
|
2011 |
10 |
Supplement 2 |
p. S31- 1 p. |
artikel |
4 |
80* A randomised, double-blind, placebo-controlled parallel group study to investigate the safety and efficacy of two doses of tiotropium bromide (2.5 μg and 5 μg) administered once daily via the Respimat® device for 12 weeks in patients with cystic fibrosis
|
Elborn, J.S. |
|
2011 |
10 |
Supplement 2 |
p. S21- 1 p. |
artikel |
5 |
353 Are elastomeric diffusers delivering what they claim?
|
Vigier, J.-P |
|
2011 |
10 |
Supplement 2 |
p. S90- 1 p. |
artikel |
6 |
184* Basophil CD203c as a potential clinically relevant biomarker in cystic fibrosis and allergic bronchopulmonary aspergillosis
|
Gernez, Y. |
|
2011 |
10 |
Supplement 2 |
p. S46- 1 p. |
artikel |
7 |
47 CFTR gene mutations and the risk for developing a pancreatic cancer: is it only a consequence of chronic inflammation?
|
Alghisi, F. |
|
2011 |
10 |
Supplement 2 |
p. S12- 1 p. |
artikel |
8 |
Chronic pulmonary infection with Stenotrophomonas maltophilia and lung function in patients with cystic fibrosis
|
Dalbøge, C.S. |
|
2011 |
10 |
Supplement 2 |
p. 318-325 8 p. |
artikel |
9 |
108 Comparative in vitro characterisation of colistimethate sodium 1 MIU/3 ml versus 2 MIU/4 ml in an eFlow® rapid Nebuliser
|
Bucholski, A. |
|
2011 |
10 |
Supplement 2 |
p. S28- 1 p. |
artikel |
10 |
125* Comparison of real time diagnostic chemistries to detect early and chronic Pseudomonas aeruginosa colonisation in cystic fibrosis patients
|
Fothergill, J.L. |
|
2011 |
10 |
Supplement 2 |
p. S32- 1 p. |
artikel |
11 |
394 Cystic fibrosis liver disease: an emerging clinical issue showing a multifactorial pathogenesis
|
Alghisi, F. |
|
2011 |
10 |
Supplement 2 |
p. S101- 1 p. |
artikel |
12 |
Diversified harmony: Supranational and domestic regulation of pediatric clinical trials in the European Union
|
Pinxten, Wim |
|
2011 |
10 |
Supplement 2 |
p. S183-S198 16 p. |
artikel |
13 |
280 Do children with cystic fibrosis really need more energy?
|
Jones, K. |
|
2011 |
10 |
Supplement 2 |
p. S73- 1 p. |
artikel |
14 |
14 Genotype-phenotype correlations of the recurrent mRNA intron 6b splicing defect, 1002-1113_1110delGAAT
|
Costa, C. |
|
2011 |
10 |
Supplement 2 |
p. S4- 1 p. |
artikel |
15 |
Impact of the A (H1N1) pandemic influenza (season 2009–2010) on patients with cystic fibrosis
|
Viviani, Laura |
|
2011 |
10 |
Supplement 2 |
p. 370-376 7 p. |
artikel |
16 |
370* Increasing incidence of cystic fibrosis being diagnosed in adulthood over time: an analysis of two decades of care
|
Weir, M. |
|
2011 |
10 |
Supplement 2 |
p. S95- 1 p. |
artikel |
17 |
244* Influence of inhaled hypertonic saline (NaCI 6%) before or during autogenic drainage on sputum weight, oxygen saturation, heart frequency and dyspnoea in cystic fibrosis patients
|
Van Ginderdeuren, F. |
|
2011 |
10 |
Supplement 2 |
p. S62- 1 p. |
artikel |
18 |
KPC-2 Carbapenemase-producing Klebsiella pneumoniae isolates from patients with Cystic Fibrosis
|
Leão, Robson S. |
|
2011 |
10 |
Supplement 2 |
p. 140-142 3 p. |
artikel |
19 |
50* Low temperature and chemical rescue affect the molecular proximity of DF508-CFTR and ENaC
|
Rennolds, J. |
|
2011 |
10 |
Supplement 2 |
p. S13- 1 p. |
artikel |
20 |
Marked increase in incidence of Achromobacter xylosoxidans infections caused by sporadic acquisition from the environment
|
Ridderberg, Winnie |
|
2011 |
10 |
Supplement 2 |
p. 466-469 4 p. |
artikel |
21 |
367 Motivational interviewing (Ml); evaluating the learning outcomes of UK CF team training
|
Duff, A. |
|
2011 |
10 |
Supplement 2 |
p. S93- 1 p. |
artikel |
22 |
262* Non-invasive (NI) rehabilitation program in cystic fibrosis patients with urinary incontinence
|
Donà, M. |
|
2011 |
10 |
Supplement 2 |
p. S66- 1 p. |
artikel |
23 |
65 Phase 3 study of ataluren (PTC124®) in nonsense mutation cystic fibrosis (nmCF): baseline data
|
Kerem, E. |
|
2011 |
10 |
Supplement 2 |
p. S17- 1 p. |
artikel |
24 |
384 Pregnancy and motherhood in women with cystic fibrosis: experience and outcomes in a regional adult UK centre
|
Etherington, C. |
|
2011 |
10 |
Supplement 2 |
p. S98- 1 p. |
artikel |
25 |
140 Retrospective analysis of isolation of non-tuberculous mycobacteria from cystic fibrosis sputum samples
|
Burnett, K. |
|
2011 |
10 |
Supplement 2 |
p. S35- 1 p. |
artikel |
26 |
171* The chitinase-like protein YKL-40 modulates cystic fibrosis lung disease
|
Hector, A. |
|
2011 |
10 |
Supplement 2 |
p. S43- 1 p. |
artikel |
27 |
247 The tolerability of nebulised meropenem within an adult cystic fibrosis centre
|
Parker-Stafford, J. |
|
2011 |
10 |
Supplement 2 |
p. S62- 1 p. |
artikel |
28 |
321 Timing of inhaled tobramycin affects intravenous tobramycin trough levels
|
Stenbit, A.E. |
|
2011 |
10 |
Supplement 2 |
p. S82- 1 p. |
artikel |
29 |
338 Variability of clinical outcomes and impact of risk factors in cystic fibrosis (CF) patients in a regional CF center in a developing country
|
Dracea, L.-L. |
|
2011 |
10 |
Supplement 2 |
p. S86- 1 p. |
artikel |
30 |
157 Variation in canide production between different strains of Pseudomonas aeruginosa
|
Gilchrist, F.J. |
|
2011 |
10 |
Supplement 2 |
p. S40- 1 p. |
artikel |
31 |
304 Vitamin K status in young children with cystic fibrosis
|
Krzyzanowska, P. |
|
2011 |
10 |
Supplement 2 |
p. S77- 1 p. |
artikel |